456 filings
Page 4 of 23
8-K
ylj gss70
1 Oct 20
Departure of Directors or Certain Officers
5:30pm
S-3ASR
gjannd339h77hgo
25 Aug 20
Automatic shelf registration
9:26am
8-K
8fq8 3o7p44swcoip
25 Aug 20
ACADIA Pharmaceuticals Acquires CerSci Therapeutics, Adds Novel Pain Program to Portfolio
9:02am
8-K
ur5ba8p0cg5c70k5blq
6 Aug 20
Departure of Directors or Certain Officers
5:21pm
S-8
ff9927whovcwowj5fr9j
6 Aug 20
Registration of securities for employees
5:19pm
8-K
30i93xbc
5 Aug 20
ACADIA Pharmaceuticals Reports Second Quarter 2020 Financial Results
4:34pm
8-K
78st loku8f44a
20 Jul 20
ACADIA Announces U.S. FDA Accepted for Filing the Supplemental New Drug Application for NUPLAZIDĀ®Ā (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
4:15pm
8-K
2wyr wduyn
29 Jun 20
Departure of Directors or Certain Officers
4:06pm
8-K
kxw4uzk
7 May 20
ACADIA Pharmaceuticals Reports First Quarter 2020 Financial Results
4:30pm
CT ORDER
2cd4ycn h0iz
6 May 20
Confidential treatment order
10:28am
8-K
ayqul cy8m2jw2k0xyag
27 Feb 20
ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
12:00am
8-K
1v6b n9gshrjn
13 Jan 20
Results of Operations and Financial Condition
6:15am
CT ORDER
cziaw5 obojx
20 Nov 19
Confidential treatment order
10:39am
8-K
gz07 uen29jyup5l8z
7 Nov 19
Departure of Directors or Certain Officers
5:01pm